Person

Philip P. Boudreau

EVP AND CFO, Abbott Laboratories

Current S&P 500 boards
0
Current roles
1
Open-market buys
$201K
Open-market sales
$3.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 23, 2026ABTBuy2,200$91.50$201K
Aug 8, 2025ABTSale5,550$134.55$747K
Jun 16, 2023ABTSale8,000$106.00$848K
Oct 25, 2021ABTSale8,000$126.49$1.0M
Mar 13, 2020ABTSale10,600$82.00$869K

SEC reporting-owner ID (CIK) 1805099 · all filings on EDGAR